rat spleen decellularization to create a spleen matrix for liver engineering

用于肝组织工程的脱细胞大鼠脾基质制备

Liver transplantation remains the only definitive treatment for end-stage liver disease1,2,3. However, the critical shortage and declining quality of donor organs have heightened the need for alternative treatments4. In the realm of regenerative medicine, bioartificial livers (BALs) utilizing decellularized liver matrix (DLM) have emerged as promising solutions5,6,7. The DLM preserves the original liver structure, including its intricate microvascular network and components of the ECM, offering a scaffold for creating transplantable BALs that could potentially alleviate liver diseases.
Despite the promise, the adoption of this technology faces challenges, particularly in sourcing suitable DLMs. Human-derived DLMs are in short supply, while those from animal sources carry the risks of disease transmission and immune rejection. In an innovative approach, our research has explored the use of a decellularized spleen matrix (DSM) as a foundation for BALs8,9,10,11. Spleens are more readily available in various medical situations, such as portal hypertension, traumatic rupture, idiopathic thrombocytopenic purpura, and donation after cardiac death. Therefore, spleens are more widely available than livers for research purposes. Patients who have undergone splenectomies do not suffer from severe conditions, further confirming the dispensability of the spleen. The microenvironment of the spleen, particularly the extracellular matrix and sinusoids, is similar to that of the liver. This makes the spleen a suitable organ for cell adhesion and proliferation in hepatocyte transplantation research. Based on these findings, our previous investigations have demonstrated that DSMs share comparable microstructures and components with DLMs and can support the survival and function of hepatocytes, including albumin and urea production. Furthermore, DSMs have been shown to enhance the hepatic differentiation of bone marrow mesenchymal stem cells, leading to improved and consistent functionality.
By employing DSMs treated with heparin, we have engineered functional BALs capable of demonstrating effective short-term anticoagulation and partial liver function compensation11. Consequently, this three-dimensional DSM holds significant promise for the advancement of liver tissue engineering and cell therapy. In this work, we present the detailed methods of harvesting rat spleens and preparing DSM that preserve the microstructures and components of the ECM.

作者聚焦：脱细胞脾基质在生物人工肝脏中的应用

来源于大鼠的脱细胞脾基质的制备

We purpose a novel strategy that involves employing a decellularized spleen matrix as an alternative scaffold to bioartificial livers. We showed the detailed procedure of harvesting rat spleen and preparing decellularized spleen matrix that preserves the macrostructures and the components of the extracellular matrix. Our protocol provides a readily available spleen matrix as an alternative to scarce donor livers.Our protocol present a method for the preparation of decellularized spleen matrices. Demonstrating efficiency, stability, and minimal invasiveness, this method maintains the spleen inherent architecture, composition, and the natural vascular network. It offers the scaffold for cell implantation and three-dimensional dynamic culture, thereby establishing a basis for advancing investigations in tissue-engineered liver.

大鼠脾脏脱细胞，创建用于肝脏工程的脾脏基质

首先，将冷冻的大鼠脾脏冷冻和解冻三次，以裂解脾细胞。在干净的工作台上，设置蠕动泵、两升储液罐、内径为 2.4 毫米的硅胶管和气泡捕集器。用去离子水填充灌注系统。保持运行 10 分钟。小心地将收获的脾脏转移到充满去离子水的容器中。接下来，将硅胶管连接到已插入脾动脉的静脉导管。用去离子水，0.1%SDS，1%Triton X-100和PBS溶液进行灌注。用含有10%青霉素链霉素的PBS填充50毫升离心管。将脱细胞的脾脏基质转移到PBS中。将其储存在零下 20 摄氏度，直到进一步实验。脾脏完全脱细胞在大约 11 小时内实现。颜色逐渐从深红色过渡到造型的浅红色，最终呈现白色半透明外观，整体形态保持不变。

rat-spleen-decellularization-to-create-spleen-matrix-for-liver

Research

JoVE Journal

Bioengineering

Rat Spleen Decellularization to Create a Spleen Matrix for Liver Engineering

64 次观看.  The First Affiliated Hospital of Xi'an Jiaotong University. 首先，将冷冻的大鼠脾脏冷冻和解冻三次，以裂解脾细胞。在干净的工作台上，设置蠕动泵、两升储液罐、内径为 2.4 毫米的硅胶管和气泡捕集器。用去离子水填充灌注系统。保持运行 10 分钟。小心地将收获的脾脏转移到充满去离子水的容器中。接下来，将硅胶管连接到已插入脾动脉的静脉导管。用去离子水，0.1%SDS，1%Triton X-100和PBS溶液进行灌注。用含有10%青霉素...

视频: 大鼠脾脏脱细胞，创建用于肝脏工程的脾脏基质

Fabrication of Decellularized Spleen Matrix Derived from Rats

Liver transplantation is the primary treatment for end-stage liver disease. However, the shortage and inadequate quality of donor organs necessitate the development of alternative therapies. Bioartificial livers (BALs) utilizing decellularized liver matrix (DLM) have emerged as promising solutions. However, sourcing suitable DLMs remains challenging. The use of a decellularized spleen matrix (DSM) has been explored as a foundation for BALs, offering a readily available alternative. In this study, rat spleens were harvested and decellularized using a combination of freeze-thaw cycles and perfusion with decellularization reagents. The protocol preserved the microstructures and components of the extracellular matrix (ECM) within the DSM. The complete decellularization process took approximately 11 h, resulting in an intact ECM within the DSM. Histological analysis confirmed the removal of cellular components while retaining the ECM's structure and composition. The presented protocol provides a comprehensive method for obtaining DSM, offering potential applications in liver tissue engineering and cell therapy. These findings contribute to the development of alternative approaches for the treatment of end-stage liver disease.

The decellularized spleen matrix (DSM) holds promising applications in the field of liver tissue engineering. This protocol outlines the procedure for preparing rat DSM, which includes harvesting rat spleens, decellularizing them through perfusion, and evaluating the resulting DSM to confirm its characteristics.

Liver transplantation is the primary treatment for end-stage liver disease. However, the shortage and inadequate quality of donor organs necessitate the ...